11q23 aberration is an additional chromosomal change in de novo acute leukemia after treatment with etoposide and mitoxantrone. [electronic resource]
Producer: 19970113Description: 264-6 p. digitalISSN:- 0361-8609
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Chromosomes, Human, Pair 11 -- drug effects
- DNA Topoisomerases, Type II -- physiology
- Enzyme Inhibitors -- pharmacology
- Etoposide -- administration & dosage
- Fatal Outcome
- Female
- Humans
- Karyotyping
- Leukemia, Monocytic, Acute -- drug therapy
- Mitoxantrone -- administration & dosage
- Neoplasm Proteins -- antagonists & inhibitors
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Topoisomerase II Inhibitors
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.